Synthesis and evaluation of 4-substituted semicarbazones of levulinic acid for anticonvulsant activity

Journal of Zhejiang University: Science

Volumn 6 B, Issue 7, 2005, Pages 617-621

  Aggarwal, Navneet ^a   Mishra, Pradeep ^b  

^a Lachoo Memorial College of Science and Technology   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Anticonvulsant; Levulinic acid; Substituted semicarbazones

Indexed keywords

EVALUATION; HYDROPHILICITY; MOLECULES; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

ANTICONVULSANT ACTIVITY; CENTRAL NERVOUS SYSTEM; EPILEPSY; INTRAPERITONEAL; LEVULINIC ACID; SUBCUTANEOUS METRAZOL; SUBSTITUTED SEMICARBAZONES;

DRUG THERAPY;

ANTICONVULSIVE AGENT; LEVULINIC ACID; SEMICARBAZONE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; SEIZURE; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; DRUG EVALUATION, PRECLINICAL; INJECTIONS, INTRAPERITONEAL; LEVULINIC ACIDS; MICE; SEIZURES; SEMICARBAZONES; TREATMENT OUTCOME;

EID: 22844436656     PISSN: 10093095     EISSN: None     Source Type: Journal    
DOI: 10.1631/jzus.2005.B0617     Document Type: Article

References (13)

1. Aggarwal, N., Mishra, P., 2004. Synthesis of 4-aryl substituted semicarbazones of some terpenes as novel anticonvulsants. J. Pharm. Pharmaceut. Sci., 7(2): 260-264.
2. Camerman, A., Camerman, N., 1980. Stereochemical Similarities in Chemically Different Antiepileptic Drugs. In: Glaser, G.H., Penry, J.K., Woodbury, D.M. (Eds.), Antiepileptic Drugs: Mechanism of Action. Raven Press, New York, p. 223-231.
3. Craig, C.R., 1997. Anticonvulsant Drugs. In: Craig, C.R., Stitzel, R.E. (Eds.), Modern Pharmacology with Clinical Application. 5th Edition, Little Brown and Company, New York, p. 391-405.
4. Dimmock, J.R., Baker, G.B., 1994. Anticonvulsant activities of 4-bromobenzaldehyde semicarbazone. Epilepsia, 35(3): 648-655.
5. Edafiogho, I.O., Scott, K.R., 1996. Anticonvulsants. In: Wolff, M.E. (Ed.), Burger's Medicinal Chemistry and Drug Discovery. 5th Edition, Vol. 3, John Wiley and Sons, New York, p. 175-260.
6. Ho, B., Crider, A.M., Stables, J.P., 2001. Synthesis and structure activity relationships of potential anticonvulsants based on 2-piperidine carboxylic acid and related pharmacophores. Eur. J. Med. Chem., 36: 265-286.
7. Krall, R.L., Penry, J.K., White, B.G., Kupferberg, H.J., Swinyard, E.A., 1978. Anticonvulsant drug development: Anticonvulsant drug screening. Epilepsia, 19: 409-428.
8. Malawska, B., 2003. Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs. Mini Rev. Med. Chem., 3: 159-165.
9. McNamara, J.O., 2001. Drugs Effective in the Therapy of the Epilepsies. In: Hardman, J.G., Eimbird, L.E., Gilman, A.G. (Eds.), Goodman and Gilman's, the Pharmacological Basis of Therapeutics. 10th Edition, The McGraw-Hill, New York, p. 521-547.
10. Pandeya, S.N., Raja, A.S., 2002. Synthesis of isatin semicarbazones as novel anticonvulsants-role of hydrogen bonding. J. Pharm. Pharmaceut. Sci., 5(3): 266-271.
11. Pandeya, S.N., Aggarwal, N., Jain, J.S., 1999. Evaluation of semicarbazones for anticonvulsant and sedative hypnotic properties. Pharmazie, 54: 300-302.
12. Pandeya, S.N., Mishra, V., Ponnilavarsan, I., Stables, J.P., 2000. Anticonvulsant activity of p-chloro phenyl substituted aryl semicarbazones-the role of primary terminal amino group. Pol. J. pharmacol, 52: 283-290.
13. Porter, R.J., Hessie, B.J., Cereghino, J.J., Gladding, G.D., Kupferberg, H.J., Scoville, B., White, B.G., 1985. Advances in the clinical development of antiepileptic drugs. Fed. Proc., 44(10): 2645-2649.